Thomas J. Schuetz
2021
In 2021, Thomas J. Schuetz earned a total compensation of $5.3M as Chief Executive Officer at Compass Therapeutics, a 106% increase compared to previous year.
Compensation breakdown
| Bonus | $450,000 |
|---|---|
| Option Awards | $2,506,000 |
| Salary | $4,000 |
| Stock Awards | $2,298,000 |
| Total | $5,258,000 |
Schuetz received $2.5M in option awards, accounting for 48% of the total pay in 2021.
Schuetz also received $450K in bonus, $4K in salary and $2.3M in stock awards.
Rankings
In 2021, Thomas J. Schuetz's compensation ranked 2,469th out of 12,406 executives tracked by ExecPay. In other words, Schuetz earned more than 80.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,469 out of 12,406 | 80th |
Division Manufacturing | 978 out of 5,492 | 82nd |
Major group Chemicals And Allied Products | 375 out of 2,368 | 84th |
Industry group Drugs | 327 out of 2,089 | 84th |
Industry Biological Products, Except Diagnostic Substances | 99 out of 452 | 78th |
Source: SEC filing on April 28, 2022.
Schuetz's colleagues
We found two more compensation records of executives who worked with Thomas J. Schuetz at Compass Therapeutics in 2021.